フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Mithra Provides an Update in the Context of Recent Market Developments Mithra Provides an Update in the Context of Recent Market...
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023 Independent global leaders in medical research...
Mithra Financial Results for First-Half 2023 Mithra Financial Results for First-Half 2023 Good progress on strategy to strengthen balance...
Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h...
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST Mithra to Hold Investor Call on H1 2023 Financial...
Publication of a Transparency Notification Received from Armistice Capital, LLC Publication of a Transparency Notification Received from...
Letter to Shareholders and Corporate Update Letter to Shareholders and Corporate Update Liege, Belgium, 11 September 2023 – 7:30 CEST –...
Mithra completes EUR 20 million private placement in equity Update of total number of voting rights (denominator) THIS ANNOUNCEMENT IS NOT...
Mithra prices private placement to raise EUR 20 million in equity THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE...
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta® Mithra and Gedeon Richter Sign Supply...
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Mithra Receives EUR 1.25 Million...
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra and Searchlight Pharma Announce Donesta® Licensing...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約